Innohep for Prophylaxis of Venous Thromboembolism in Brain Tumor Patients

This study has been completed.
Sponsor:
Collaborator:
Celgene Corporation
Information provided by (Responsible Party):
Duke University
ClinicalTrials.gov Identifier:
NCT00629447
First received: February 27, 2008
Last updated: January 4, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2009
  Primary Completion Date: March 2007 (Final data collection date for primary outcome measure)